Explore the vast range of titles available.

\"Since the 1980s the bird life of the Cotswolds has seen significant changes, many of them subtle but some spectacular. This beautifully illustrated and extensively researched book, the product of five years' field work exposes these changes with the aid of simple and clear colour maps which give not only a detailed but easily understood picture of the breeding distributions of bird species in the area today, but also a comparison with 20 years ago. The maps are accompanied by descriptive accounts for each species, often containing fascinating local information. The book discusses the relative difficulties of surveying the different species, which will be of help to others undertaking the same task elsewhere. It is richly illustrated by colour photographs of the birds and their habitats. Its easy style and clarity will make this book of great interest not only to ornithologists, but to everyone with a concern for the natural environment of the Cotswolds, and to anyone planning a visit to this Area of Outstanding Natural Beauty.\"--Jacket.

Background Although tuberculosis (TB) is a curable disease, treatment is complex and prolonged, requiring considerable commitment from patients. This study aimed to understand the common perspectives of TB patients across Brazil, Russia, India, China, and South Africa throughout their disease journey, including the emotional, psychological, and practical challenges that patients and their families face. Methods This qualitative market research study was conducted between July 2020 and February 2021. Eight TB patients from each country ( n  = 40) completed health questionnaires, video/telephone interviews, and diaries regarding their experiences of TB. Additionally, 52 household members were interviewed. Patients at different stages of their TB treatment journey, from a range of socioeconomic groups, with or without TB risk factors were sought. Anonymized data underwent triangulation and thematic analysis by iterative coding of statements. Results The sample included 23 men and 17 women aged 13–60 years old, with risk factors for TB reported by 23/40 patients. Although patients were from different countries and cultural backgrounds, experiencing diverse health system contexts, five themes emerged as common across the sample. 1) Economic hardship from loss of income and medical/travel expenses. 2) Widespread stigma, delaying presentation and deeply affecting patients’ emotional wellbeing. 3) TB and HIV co-infection was particularly challenging, but increased TB awareness and accelerated diagnosis. 4) Disruption to family life strained relationships and increased patients’ feelings of isolation and loneliness. 5) The COVID-19 pandemic made it easier for TB patients to keep their condition private, but disrupted access to services. Conclusions Despite disparate cultural, socio-economic, and systemic contexts across countries, TB patients experience common challenges. A robust examination of the needs of individual patients and their families is required to improve the patient experience, encourage adherence, and promote cure, given the limitations of current treatment.

Significant disparities exist throughout the patient journey and ultimately in health outcomes across diverse patient populations with Alzheimer's Disease (AD). The aim of this qualitative market research was to better understand the experiences of a diverse group of patients living with AD, to support inclusive and patient-centered approaches in medicine development. Patients diagnosed with mild cognitive impairment (MCI) and dementia due to AD (mild, moderate, or severe), and care partners of patients living with AD, were included in this research. Participants were interviewed one-to-one or as dyads, with follow-up ethnographic tasks. The research included a diverse group of patients across geography, ethnicity, race and employment status. Data was thematically analysed. A total of 65 participants (29 patients and 36 care partners) from the United States (US; 15%), Canada (20%), China (17%), France (12%), Germany (17%), and Italy (18%) were included. The mean patient age was 65.7 years, with the reported stage of disease as MCI or mild dementia due to AD (40%) and moderate or severe dementia due to AD (60%). The analysis revealed an overall consistent patient journey including diagnosis, day-to-day living, care, and treatment experiences. Some variations were revealed in the lived experiences of different patient groups. Many patients from diverse ethnic/racial groups emphasized the importance of family involvement in care and treatment decisions. Black participants in the US expressed concerns with seeking treatment due to lack of representation in medicine development and the need for future medications to be explicitly trialled in participants from ethnic/racial minorities. Asian participants in China, the US and Canada reported major stigma associated with AD, which delayed them in seeking medical help. Across all countries, patients living in rural locations experienced increased financial and logistical burden in accessing healthcare. These findings underscore the need to better understand the unique experiences faced by diverse populations of patients when considering the process for AD medicine development. A patient-centered approach could help increase trust and ultimately improve the patient experiences and health outcomes for diverse populations affected by AD.

Significant disparities exist throughout the patient journey and ultimately in health outcomes across diverse patient populations with Alzheimer's Disease (AD). The aim of this qualitative market research was to better understand the experiences of a diverse group of patients living with AD, to support inclusive and patient‐centered approaches in medicine development. Patients diagnosed with mild cognitive impairment (MCI) and dementia due to AD (mild, moderate, or severe), and care partners of patients living with AD, were included in this research. Participants were interviewed one‐to‐one or as dyads, with follow‐up ethnographic tasks. The research included a diverse group of patients across geography, ethnicity, race and employment status. Data was thematically analysed. A total of 65 participants (29 patients and 36 care partners) from the United States (US; 15%), Canada (20%), China (17%), France (12%), Germany (17%), and Italy (18%) were included. The mean patient age was 65.7 years, with the reported stage of disease as MCI or mild dementia due to AD (40%) and moderate or severe dementia due to AD (60%). The analysis revealed an overall consistent patient journey including diagnosis, day‐to‐day living, care, and treatment experiences. Some variations were revealed in the lived experiences of different patient groups. Many patients from diverse ethnic/racial groups emphasized the importance of family involvement in care and treatment decisions. Black participants in the US expressed concerns with seeking treatment due to lack of representation in medicine development and the need for future medications to be explicitly trialled in participants from ethnic/racial minorities. Asian participants in China, the US and Canada reported major stigma associated with AD, which delayed them in seeking medical help. Across all countries, patients living in rural locations experienced increased financial and logistical burden in accessing healthcare. These findings underscore the need to better understand the unique experiences faced by diverse populations of patients when considering the process for AD medicine development. A patient‐centered approach could help increase trust and ultimately improve the patient experiences and health outcomes for diverse populations affected by AD.

Example standardized sensor node platforms have been developed and deployed, and custom hardware has also been used to meet the energy and performance constraints of specific situations. The intent and objectives of a deployment suggest many different organizing paradigms for sensor networks, although a very common architecture for sensor networks, due mainly to the limited range of individual transceivers, requires nodes to collaboratively forward data on behalf of their“K11012_C019.tex” — 467[#3]peers via multihop routing. Some situations in which nodes are static and node failure rates are low concentrate upon initiating long-lived routes with an explicit establishment phase, while others favored in more dynamic and less predictable environments, such as wildlife-monitoring protocol mentioned previously by Juang et al. [3], concentrate upon database merging via flooding to deliver messages progressively to the sink node.

If any readers are disturbed by the correspondence about irritating...